Cargando…
Sinomenine derivative YL064: a novel STAT3 inhibitor with promising anti-myeloma activity
Autores principales: | Wang, Yingying, Wu, Linlin, Cai, Haiyan, Lei, Hu, Ma, Chun-Min, Yang, Li, Xu, Hanzhang, Zhu, Qi, Yao, Zhujun, Wu, Yingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202322/ https://www.ncbi.nlm.nih.gov/pubmed/30361529 http://dx.doi.org/10.1038/s41419-018-1147-z |
Ejemplares similares
-
YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells
por: Wang, Yingying, et al.
Publicado: (2018) -
YL064 activates proteasomal-dependent degradation of c-Myc and synergistically enhances the anti-tumor activity of ABT-199 in diffuse large B cell lymphoma
por: Shan, Huizhuang, et al.
Publicado: (2020) -
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma
por: Nakayama, Kazuhide, et al.
Publicado: (2018) -
Multiple Myeloma and the Kidney
por: Cancarini, Giovanni, et al.
Publicado: (2021) -
Agranulocytosis Induced by Sinomenine Hydrochloride
por: Chen, Juerong, et al.
Publicado: (2017)